Dr. R. VERSCUREN nucleaire geneeskunde (SPRL)

Active

VAT

BE 0843.218.228

Address

Kapelleke 3

3202 Aarschot

Established

23-01-2012

Principal activity

Specialist medical practice activities

Try for free

Crisis resilience of Dr. R. VERSCUREN nucleaire geneeskunde

Which companies are best armed against current economic trends and the energy crisis?

2023		2022		2021		2020
Profit/Loss	€182,935	109%	€87,682	18%	€74,509	41%	€52,761
Equity	€472,477	36%	€348,341	25%	€279,054	18%	€237,362
Gross margin	€264,327	97%	€134,042	3%	€129,786	13%	€115,038

Publications in the Belgian Official Journal for Dr. R. VERSCUREN nucleaire geneeskunde

Type	Date	Pdf	Subject
	21-06-2018		Resignations - Appointments (NL)
	20-07-2012		Registered Office - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	22-05-2012		Miscellaneous (FR)
	13-02-2012		Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Sources

Frequently asked questions

What is the VAT number of Dr. R. VERSCUREN nucleaire geneeskunde?

The VAT number of Dr. R. VERSCUREN nucleaire geneeskunde is BE0843218228.

When was Dr. R. VERSCUREN nucleaire geneeskunde founded?

Dr. R. VERSCUREN nucleaire geneeskunde was founded on 23-01-2012.

What is the address of Dr. R. VERSCUREN nucleaire geneeskunde?

The current registered office of Dr. R. VERSCUREN nucleaire geneeskunde is located at Kapelleke 3, 3202 Aarschot.

When was the last time Dr. R. VERSCUREN nucleaire geneeskunde filed their annual financial statements?

The most recent financial statements of Dr. R. VERSCUREN nucleaire geneeskunde were filed on 30-04-2024. You can view them here.

How many employees does Dr. R. VERSCUREN nucleaire geneeskunde have?

There are currently no employees working at Dr. R. VERSCUREN nucleaire geneeskunde or no workforce information is available.

What is the annual turnover of Dr. R. VERSCUREN nucleaire geneeskunde?

At the time of its most recent financial statements, Dr. R. VERSCUREN nucleaire geneeskunde did not publish any turnover figures. Dr. R. VERSCUREN nucleaire geneeskunde reported a gross margin of €264,327.13.